|
PLYX Polaryx Therapeutics, Inc 2075320 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,544,000.00 |
| Balance Sheet |
|
Current Assets
|
$3,502,000.00 |
|
Assets
|
$3,502,000.00 |
|
Current Liabilities
|
$1,014,000.00 |
|
Liabilities
|
$1,014,000.00 |
|
Equity
|
$2,488,000.00 |
|
Shares Out
|
47343297.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,063,000.00 |
| Market Analysis |
Market Cap
|
$101,788,088.55 |
|
Price
|
$2.23 |
|
BVPS
|
0.05 |
|
PB
|
43.00 |
|
EPS
|
-0.05 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PLYX documents filed with the SEC.
PLYX Filings
Clear
